← All investors
Apple Tree Partners
15 portfolio companies · 3 on the map · $481.9M raised · 3 cities
Portfolio map
3 Apple Tree Partners portfolio companies on the map.
Portfolio companies

Stoke Therapeutics
Bedford
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Biotechnology Research$360.1MEst. 2017
Ascidian Therapeutics
Boston
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
Biotechnology$90MEst. 2020
QualDerm Partners
Brentwood
QualDerm Partners provides strategic leadership and practice management services
Hospitals and Health Care$31.8MEst. 2014Hiring fast
More portfolio companies
12 more Apple Tree Partners investments we track beyond the map.
Galvanize TherapeuticsRedwood City · Series C
Replicate BioscienceSan Diego · Series A
Deep Apple TherapeuticsNew York · Series A
Aurinia PharmaceuticalsVictoria · Post-IPO Equity
BraeburnPlymouth Meeting · Debt Financing
Aethon TherapeuticsNew York · Series A
Initial TherapeuticsSouth San Francisco · Series A
Gala TherapeuticsMenlo Park · Venture
Nereid TherapeuticsCambridge · Series A
DermiraMenlo Park · Series C
Chinook TherapeuticsVancouver · Post-IPO Equity
Gloucester PharmaceuticalsCambridge · Series D
Portfolio map
3 Apple Tree Partners portfolio companies on the map.